A newly diagosis lung cancer at superior segment of left lower lobe during the screening programme. Patient has emphysematous changes.
Ankara/TR, 2 Rochester, MN/US, 3 Nanjing/CN
Keywords:
Thorax, Oncology, CT, Screening, Epidemiology, Cancer, Chronic obstructive airways disease DOI: 10.1594/ecr2015/C-2328
Any information contained in this pdf file is automatically generated from digital material submitted to EPOS by third parties in the form of scientific presentations. References to any names, marks, products, or services of third parties or hypertext links to thirdparty sites or information are provided solely as a convenience to you and do not in any way constitute or imply ECR's endorsement, sponsorship or recommendation of the third party, information, product or service. ECR is not responsible for the content of these pages and does not make any representations regarding the content or accuracy of material in this file. As per copyright regulations, any unauthorised use of the material or parts thereof as well as commercial reproduction or multiple distribution by any traditional or electronically based reproduction/publication method ist strictly prohibited. You agree to defend, indemnify, and hold ECR harmless from and against any and all claims, damages, costs, and expenses, including attorneys' fees, arising from or related to your use of these pages. Please note: Links to movies, ppt slideshows and any other multimedia files are not available in the pdf version of presentations. www.myESR.org
Pulmonary emphysema is a pathological lesion, known as abnormal permanent enlargement of the airspaces distal to the terminal bronchioles with destruction of their walls without obvious fibrosis (1) .
The use of an adequate resolution computed tomography (CT) scan of the lung has been advocated as the Gold standard for non-invasive detection of emphysema (2) . CT can provide excellent anatomical detail to quantitatively detect and characterize the presence and the severity of emphysema. Complete CT scan data as well as clinical information were available for all enrolled subjects, allowing us to evaluate how well the clinical diagnosis for emphysema conforms to the CT diagnosis and to assess the accurate contribution of emphysema on lung cancer risk.
The aim of this study is to conduct a clinic-based case-control study in order to assess the association between CT-diagnosed emphysema and lung cancer risk.
In this study, 565 primary lung cancer cases were enrolled though a prospective lung cancer cohort at Mayo Clinic, and 450 controls were smokers participating in a lung cancer screening study in the same institution using spiral CT. Cases and controls were frequency matched on age, gender, race, smoking status, and residential region.
Radiological diagnosis and quantification of emphysema was made through direct interpretation and evaluation of the CT examinations (all via volumetric technology) by an experienced thoracic radiologist (SJS) (3, 4, 5) , who was blinded to case-control identity and clinical diagnosis of emphysema. A detailed visual analysis of the entire lung examination with an estimate of the percentage of lung tissue destroyed by emphysema was performed, on PACS system. Grading of emphysema was performed by comparing research subject CT examinations to computer-aided quantitative standard images generated by using -950 HU as the threshold for emphysema (3) . Emphysema was analyzed as a categorical variable by using the following categories: 0%, >0% and <5%, #5% and <10%, and #10%. Quality control was assured by repeating calls of a random, blind sample.
Results

Comparison of CT and clinical diagnosis for emphysema
In 565 lung cancer cases, if using the >0% criterion, 77% of the cases had emphysema by CT diagnosis, while clinical diagnosis only detected 36% .
If using the #5% criterion, 43% of the cases had real emphysema, while clinical diagnosis detected 27% .
If using the #10% criterion, 28% of the cases had emphysema, and clinical diagnosis detected 20% .
In 450 controls, there were much more striking differences in emphysema diagnosis between CT and clinical assessment. Using the criterion >0%, #5%, or #10%, only 7% (4.4% versus 60%), 20% (4% versus 20%), or 18% (2% versus 11%) of the CT-diagnosed emphysema could be clinically diagnosed, respectively.
The sensitivity of the clinical diagnosis was much lower in the controls than in the cases: nearly 80% of healthy smokers with emphysematous changes in the lung were underdiagnosed. Overall, the diagnostic performance of clinical assessment compared to CT diagnosis was low .
Effect of emphysema on lung cancer risk
There was a significant association between emphysema and lung cancer risk. Among subjects with any evidence of emphysema on CT, lung cancer risk increased 2.79-fold. Lung cancer risk increased up to 3.80-fold if emphysema percentage on CT was #5%, but did not increase further when emphysema percentage on CT became #10%.
Among heavy smokers (cigarette smoking #40 pack-years), lung cancer risk contributed by emphysema was much higher than in moderate smokers (20-40 pack-years). Among the older age group (#65 years old), the emphysema-associated lung cancer risk was estimated at 3.47-fold;
whereas, among the younger age group (<65 years old), the emphysema-associated lung cancer risk was 4.62-fold. Regarding cell type, having emphysema increased the risk of all three major cell types of lung cancer (adenocarcinoma, squamous cell carcinoma, and small-cell lung cancer) significantly, with the strongest effect on small-cell lung cancer.
Fig. 1:
A malign mass with spiculated borders at the left upper lobe at a patient with mild emphysematous changes.
